Accès ouvert
A Triple-Blinded Randomized Control Trial to Evaluate the Safety and Immunogenicity of Fractional Doses of COVID-19 Vaccines (ChAd0x1, AD26.COV2.S, and BNT162B2) Among Nigeria Adults: The SIFCoVAN Trial
Résumé
Citer ce document
Zaidat, M., Salako, A., James, A., Sabdat, E., Oluwatosin, O., Fehintola, I., Ifeoma, I., Olusola, A., Rofiah, O., Henry, E., Magaret, E., Kazeem, A., Ifedola, O., Muinah, F., Azuka, O., Uhenna, E., Ifeoma, E., Fraden, B., Abdulrasheed, O., Adigun, I., Jimoh, Y., Ruth, A., Joy, O., Ogechi, N., Louisa, O., Dorcas, O., Ezeanowi, R., Adedoyin, A., Osho, A., Garba, A., Yahya, B., Maiyaki, M., Ogochukwu, E., Ben, E., Abiodun, I., Adigwe, O., Mojisola, A., Shuaib, F., Chukwujekwu, E., Lawal, S.
(2025). A Triple-Blinded Randomized Control Trial to Evaluate the Safety and Immunogenicity of Fractional Doses of COVID-19 Vaccines (ChAd0x1, AD26.COV2.S, and BNT162B2) Among Nigeria Adults: The SIFCoVAN Trial.
https://doi.org/10.21203/rs.3.rs-5466406/v1
Accès au document
Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter
Voir l'article sur le site de la revueAuteur(s)
Musa Adesola Zaidat
AO Salako
Ayorinde Babatunde James
Ekama Sabdat
Odubela Olaseni Oluwatosin
Ige Fehintola
Idigbe Eugenia Ifeoma
Ajibaye Olusola
Odubela Olayemi Rofiah
Egharevba Henry
Ekpenyong Magaret
Adeneye Adeniyi Kazeem
Olojo Isimeme Ifedola
Fowora Muinah
Okwuraiwe Azuka
Elemuwa Uhenna
Ezenyi Ifeoma
Bitrus Fraden
Oba Abdulrasheed
Idris Ganiu Adigun
Yusuf Jimoh
Akande Ibukun Ruth
Ogunwale Joy
Nwaiwu Stephine Ogechi
Omale Ojoma Louisa
Oyewunmi Oluwatobiloba Dorcas
Rufina Ezeanowi
Agbabiaka Adedoyin
Abdulhakeem Osho
Abdullah Garba
Bello Yahya
Musa Baba Maiyaki
Ezejiofor Ogochukwu
Ejiro Ben
Iwalokun Bamidele Abiodun
Obi Peter Adigwe
Adeyeye Christianah Mojisola
Faisal Shuaib
Ezechi Oliver Chukwujekwu
Salako Babatunde Lawal
Statistiques
Consultations : 1
Téléchargements : 0